Cited by 391T-cell and B-cell ImmunologyImmunotherapy and Immune ResponsesCancer Immunotherapy and Biomarkers

The DOI matches its Crossref record; 278 of the 278 references it cites were found in a registry or an index.

Intrinsic and extrinsic control of peripheral T‐cell tolerance by costimulatory molecules of the CD28/ B7 family

Open access

Bour‐Jordan, Hélène, Esensten, Jonathan H., Martinez‐Llordella, Marc, Penaranda, Cristina, Stumpf, Melanie, Bluestone, Jeffrey A.·2011·Immunological Reviews

DOI 10.1111/j.1600-065x.2011.01011.xPMC PMC3077803

Open this paper in CoChat — free account

Abstract

Summary: Positive and negative costimulation by members of the CD28 family is critical for the development of productive immune responses against foreign pathogens and their proper termination to prevent inflammation‐induced tissue damage. In addition, costimulatory signals are critical for the establishment and maintenance of peripheral tolerance. This paradigm has been established in many animal models and has led to the development of immunotherapies targeting costimulation pathways for the treatment of cancer, autoimmune disease, and allograft rejection. During the last decade, the complexity of the biology of costimulatory pathways has greatly increased due to the realization that costimulation does not affect only effector T cells but also influences regulatory T cells and antigen‐presenting cells. Thus, costimulation controls T‐cell tolerance through both intrinsic and extrinsic pathways. In this review, we discuss the influence of costimulation on intrinsic and extrinsic pathways of peripheral tolerance, with emphasis on members of the CD28 family, CD28, cytotoxic T‐lymphocyte antigen‐4 (CTLA‐4), and programmed death‐1 (PD‐1), as well as the downstream cytokine interleukin‐1 (IL‐2).

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1111/j.1600-065x.2011.01011.x

Cites

278 of 278 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

PD-1 and PD-L1 Immune Checkpoint Blockade to Treat Breast Cancer
Hartkopf, A. D., Taran, F., Wallwiener, M., Walter, C. B., Krämer, B., Grischke, E., & Brucker, S. Y. (2016) · Breast Care · doi:10.1159/000453569 · Cited by 30,989
Adverse Renal Effects of Immune Checkpoint Inhibitors: A Narrative Review
Wanchoo, R., Karam, S., Uppal, N. N., Barta, V. S., Deray, G., Devoe, C., Launay‐Vacher, V., Jhaveri, K. D., & on behalf of Cancer and Kidney International Network Workgroup on Immune Checkpoint Inhibitors (2017) · American Journal of Nephrology · doi:10.1159/000455014 · Cited by 15,320
Improved Survival with Ipilimumab in Patients with Metastatic Melanoma
Hodi, F. S., O'Day, S. J., McDermott, D. F., Weber, R. W., Sosman, J. A., Haanen, J. B., Gonzalez, R., Robert, C., Schadendorf, D., Hassel, J. C., et al. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa1003466 · Cited by 15,155
Foxp3 programs the development and function of CD4+CD25+ regulatory T cells
Fontenot, J. D., Gavin, M. A., & Rudensky, A. Y. (2003) · Nature Immunology · doi:10.1038/ni904 · Cited by 7,745
Regulatory T Cells and Immune Tolerance
Sakaguchi, S., Yamaguchi, T., Nomura, T., & Ono, M. (2008) · Cell · doi:10.1016/j.cell.2008.05.009 · Cited by 5,475
The immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome (IPEX) is caused by mutations of FOXP3
Bennett, C. L., Christie, J., Ramsdell, F., Brunkow, M., Ferguson, P., Whitesell, L., Kelly, T., Saulsbury, F., Chance, P., & Ochs, H. (2001) · Nature Genetics · doi:10.1038/83713 · Cited by 3,576
Tolerogenic Dendritic Cells
Steinman, R. M., Hawiger, D., & Nussenzweig, M. C. (2003) · Annual Review of Immunology · doi:10.1146/annurev.immunol.21.120601.141040 · Cited by 3,162
CTLA-4 Control over Foxp3 + Regulatory T Cell Function
Wing, K., Onishi, Y., Prieto-Martin, P., Yamaguchi, T., Miyara, M., Fehervari, Z., Nomura, T., & Sakaguchi, S. (2008) · Science · doi:10.1126/science.1160062 · Cited by 2,956
PD-L2 is a second ligand for PD-1 and inhibits T cell activation
Latchman, Y., Wood, C. R., Chernova, T., Chaudhary, D., Borde, M., Chernova, I., Iwai, Y., Long, A. J., Brown, J. A., Nunes, R., et al. (2001) · Nature Immunology · doi:10.1038/85330 · Cited by 2,955
Loss of CTLA-4 leads to massive lymphoproliferation and fatal multiorgan tissue destruction, revealing a critical negative regulatory role of CTLA-4
Tivol, E. A., Borriello, F., Schweitzer, A. N., Lynch, W. P., Bluestone, J. A., & Sharpe, A. H. (1995) · Immunity · doi:10.1016/1074-7613(95)90125-6 · Cited by 2,914
Self-citation
Development of Lupus-like Autoimmune Diseases by Disruption of the PD-1 Gene Encoding an ITIM Motif-Carrying Immunoreceptor
Nishimura, H., Nose, M., Hiai, H., Minato, N., & Honjo, T. (1999) · Immunity · doi:10.1016/s1074-7613(00)80089-8 · Cited by 2,749
CD28/B7 SYSTEM OF T CELL COSTIMULATION
Lenschow, D. J., Walunas, T. L., & Bluestone, J. A. (1996) · Annual Review of Immunology · doi:10.1146/annurev.immunol.14.1.233 · Cited by 2,717
Self-citation
Naturally arising Foxp3-expressing CD25+CD4+ regulatory T cells in immunological tolerance to self and non-self
Sakaguchi, S. (2005) · Nature Immunology · doi:10.1038/ni1178 · Cited by 2,669
CD4+CD25+ Immunoregulatory T Cells Suppress Polyclonal T Cell Activation In Vitro by Inhibiting Interleukin 2 Production
Thornton, A. M., & Shevach, E. M. (1998) · The Journal of Experimental Medicine · doi:10.1084/jem.188.2.287 · Cited by 2,637
SH2 domains recognize specific phosphopeptide sequences
Songyang, Z. (1993) · Cell · doi:10.1016/0092-8674(93)90404-e · Cited by 2,620
Projection of an Immunological Self Shadow Within the Thymus by the Aire Protein
Anderson, M. S., Venanzi, E. S., Klein, L., Chen, Z.-B., Berzins, S., Turley, S., von Boehmer, H., Bronson, R., Dierich, A., Benoist, C., et al. (2002) · Science · doi:10.1126/science.1075958 · Cited by 2,582
Ido expression by dendritic cells: tolerance and tryptophan catabolism
Mellor, A. L., & Munn, D. H. (2004) · Nature Reviews Immunology · doi:10.1038/nri1457 · Cited by 2,341
The B7 family revisited
Greenwald, R. J., Freeman, G. J., & Sharpe, A. H. (2005) · Annual Review of Immunology · doi:10.1146/annurev.immunol.23.021704.115611 · Cited by 2,318
The PD‐1 pathway in tolerance and autoimmunity
Francisco, L. M., Sage, P. T., & Sharpe, A. H. (2010) · Immunological Reviews · doi:10.1111/j.1600-065x.2010.00923.x · Cited by 2,300
Immunologic self-tolerance maintained by CD25(+)CD4(+) regulatory T cells constitutively expressing cytotoxic T lymphocyte-associated antigen 4
Takahashi, T., Tagami, T., Yamazaki, S., Uede, T., Shimizu, J., Sakaguchi, N., Mak, T. W., & Sakaguchi, S. (2000) · The Journal of Experimental Medicine · doi:10.1084/jem.192.2.303 · Cited by 2,233
CTLA-4 can function as a negative regulator of T cell activation
Walunas, T. L., Lenschow, D. J., Bakker, C. Y., Linsley, P. S., Freeman, G. J., Green, J. M., Thompson, C. B., & Bluestone, J. A. (1994) · Immunity · doi:10.1016/1074-7613(94)90071-x · Cited by 2,222
Self-citation
Association of the T-cell regulatory gene CTLA4 with susceptibility to autoimmune disease
Ueda, H., Howson, J. M. M., Esposito, L., Heward, J., Snook, Chamberlain, G., Rainbow, D. B., Hunter, K. M. D., Smith, A. N., Di Genova, G., et al. (2003) · Nature · doi:10.1038/nature01621 · Cited by 2,175
Cytokine Storm in a Phase 1 Trial of the Anti-CD28 Monoclonal Antibody TGN1412
Suntharalingam, G., Perry, M. R., Ward, S., Brett, S. J., Castello-Cortes, A., Brunner, M. D., & Panoskaltsis, N. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa063842 · Cited by 2,164
PD-L1 regulates the development, maintenance, and function of induced regulatory T cells
Francisco, L. M., Salinas, V. H., Brown, K. E., Vanguri, V. K., Freeman, G. J., Kuchroo, V. K., & Sharpe, A. H. (2009) · The Journal of Experimental Medicine · doi:10.1084/jem.20090847 · Cited by 2,072
B7/CD28 Costimulation Is Essential for the Homeostasis of the CD4+CD25+ Immunoregulatory T Cells that Control Autoimmune Diabetes
Salomon, B. L., Lenschow, D. J., Rhee, L., Ashourian, N., Singh, B., Sharpe, A. H., & Bluestone, J. A. (2000) · Immunity · doi:10.1016/s1074-7613(00)80195-8 · Cited by 2,058
Self-citation
Autoimmune Dilated Cardiomyopathy in PD-1 Receptor-Deficient Mice
Nishimura, H., Okazaki, T., Tanaka, Y., Nakatani, K., Hara, M., Matsumori, A., Sasayama, S., Mizoguchi, A., Hiai, H., Minato, N., et al. (2001) · Science · doi:10.1126/science.291.5502.319 · Cited by 1,868
A function for interleukin 2 in Foxp3-expressing regulatory T cells
Fontenot, J. D., Rasmussen, J. P., Gavin, M. A., & Rudensky, A. Y. (2005) · Nature Immunology · doi:10.1038/ni1263 · Cited by 1,819
Ulcerative colitis-like disease in mice with a disrupted interleukin-2 gene
Sadlack, B., Merz, H., Schorle, H., Schimpl, A., Feller, A. C., & Horak, I. D. (1993) · Cell · doi:10.1016/0092-8674(93)80067-o · Cited by 1,744
Thymic selection of CD4+CD25+ regulatory T cells induced by an agonist self-peptide
Jordan, M. S., Boesteanu, A. C., Reed, A. J., Petrone, A. L., Holenbeck, A. E., Lerman, M. A., Naji, A., & Caton, A. J. (2001) · Nature Immunology · doi:10.1038/86302 · Cited by 1,661
Immunologic self-tolerance maintained by CD25+CD4+ naturally anergic and suppressive T cells: induction of autoimmune disease by breaking their anergic/suppressive state.
Takahashi, T., Kuniyasu, Y., Toda, M., Sakaguchi, N., Itoh, M., Iwata, M., Shimizu, J., & Sakaguchi, S. (1998) · International Immunology · doi:10.1093/intimm/10.12.1969 · Cited by 1,566
Clonal Expansion Versus Functional Clonal Inactivation: A Costimulatory Signaling Pathway Determines The Outcome Of T Cell Antigen Receptor Occupancy
Mueller, D. L., Jenkins, M. K., & Schwartz, R. H. (1989) · Annual Review of Immunology · doi:10.1146/annurev.iy.07.040189.002305 · Cited by 1,505
T cell anergy
Schwartz, R. H. (2003) · Annual Review of Immunology · doi:10.1146/annurev.immunol.21.120601.141110 · Cited by 1,487
The CD28 Signaling Pathway Regulates Glucose Metabolism
Frauwirth, K. A., Riley, J. L., Harris, M. H., Parry, R. V., Rathmell, J. C., Plas, D. R., Elstrom, R. L., June, C. H., & Thompson, C. B. (2002) · Immunity · doi:10.1016/s1074-7613(02)00323-0 · Cited by 1,475 · cited 1×
“Additionally, CD28 costimulation is required to increase glucose uptake and glycolysis through both phosphoinositol 3-kinase (PI3K)-Akt-dependent and -independent pathways to meet elevated metabolic demand following T-cell activation (36).”
Background
Robust associations of four new chromosome regions from genome-wide analyses of type 1 diabetes
Finland, G. O. T. 1. D. I., Todd, J. A., the Wellcome Trust Case Control Consortium, Walker, N. M., Cooper, J. D., Smyth, D. J., Downes, K., Plagnol, V., Bailey, R., Nejentsev, S., et al. (2007) · Nature Genetics · doi:10.1038/ng2068 · Cited by 1,456
A functional variant of lymphoid tyrosine phosphatase is associated with type I diabetes
Bottini, N., Musumeci, L., Alonso, A., Rahmouni, S., Nika, K., Rostamkhani, M., MacMurray, J. P., Meloni, T., Lucarelli, P., Pellecchia, M., et al. (2004) · Nature Genetics · doi:10.1038/ng1323 · Cited by 1,419
Expression of Helios, an Ikaros Transcription Factor Family Member, Differentiates Thymic-Derived from Peripherally Induced Foxp3+ T Regulatory Cells
Thornton, A. M., Korty, P. E., Tran, D. Q., Wohlfert, E. A., Murray, P. E., Belkaid, Y., & Shevach, E. M. (2010) · The Journal of Immunology · doi:10.4049/jimmunol.0904028 · Cited by 1,382
Modulation of tryptophan catabolism by regulatory T cells
Fallarino, F., Grohmann, U., Hwang, K. W., Orabona, C., Vacca, C., Bianchi, R., Belladonna, M. L., Fioretti, M. C., Alegre, M., & Puccetti, P. (2003) · Nature Immunology · doi:10.1038/ni1003 · Cited by 1,375
Instability of the transcription factor Foxp3 leads to the generation of pathogenic memory T cells in vivo
Zhou, X., Bailey-Bucktrout, S. L., Jeker, L. T., Peñaranda, C., Martínez‐Llordella, M., Ashby, M., Nakayama, M., Rosenthal, W. L., & Bluestone, J. A. (2009) · Nature Immunology · doi:10.1038/ni.1774 · Cited by 1,374
Self-citation
Natural versus adaptive regulatory T cells
Bluestone, J. A., & Abbas, A. K. (2003) · Nature reviews. Immunology · doi:10.1038/nri1032 · Cited by 1,319
Self-citation
Identification and Functional Characterization of Human Cd4+Cd25+ T Cells with Regulatory Properties Isolated from Peripheral Blood
Jonuleit, H., Schmitt, E., Stassen, M., Tuettenberg, A., Knop, J., & Enk, A. (2001) · The Journal of Experimental Medicine · doi:10.1084/jem.193.11.1285 · Cited by 1,255
Tissue expression of PD-L1 mediates peripheral T cell tolerance
Keir, M. E., Liang, S. C., Guleria, I., Latchman, Y. E., Qipo, A., Albacker, L. A., Koulmanda, M., Freeman, G. J., Sayegh, M. H., & Sharpe, A. H. (2006) · The Journal of Experimental Medicine · doi:10.1084/jem.20051776 · Cited by 1,244
Abatacept for Rheumatoid Arthritis Refractory to Tumor Necrosis Factor α Inhibition
Genovese, M. C., Becker, J., Schiff, M. H., Luggen, M. E., Sherrer, Y., Kremer, J. M., Birbara, C. A., Box, J., Natarajan, K., Nuamah, I. F., et al. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa050524 · Cited by 1,239
Homeostatic maintenance of natural Foxp3 + CD25+ CD4+ regulatory T cells by interleukin (IL)-2 and induction of autoimmune disease by IL-2 neutralization
Setoguchi, R., Hori, S., Takahashi, T., & Sakaguchi, S. (2005) · The Journal of Experimental Medicine · doi:10.1084/jem.20041982 · Cited by 1,234
In Vitro–expanded Antigen-specific Regulatory T Cells Suppress Autoimmune Diabetes
Tang, Q., Henriksen, K., Bi, M., Finger, E. B., Szot, G. L., Ye, J., Masteller, E. L., McDevitt, H. O., Bonyhadi, M. L., & Bluestone, J. A. (2004) · The Journal of Experimental Medicine · doi:10.1084/jem.20040139 · Cited by 1,232
Self-citation
CD28 costimulation can promote T cell survival by enhancing the expression of Bcl-xL
Boise, L., Minn, A. J., Noel, P. J., June, C. H., Accavitti, M. A., Lindsten, T., & Thompson, C. B. (1995) · Immunity · doi:10.1016/1074-7613(95)90161-2 · Cited by 1,219
CTLA-4–Ig regulates tryptophan catabolism in vivo
Grohmann, U., Orabona, C., Fallarino, F., Vacca, C., Calcinaro, F., Falorni, A., Candeloro, P., Belladonna, M. L., Bianchi, R., Fioretti, M. C., et al. (2002) · Nature Immunology · doi:10.1038/ni846 · Cited by 1,204
Regulatory T cells exert checks and balances on self tolerance and autoimmunity
Wing, K., & Sakaguchi, S. (2009) · Nature Immunology · doi:10.1038/ni.1818 · Cited by 1,140
Long-Term Survival of Xenogeneic Pancreatic Islet Grafts Induced by CTLA4lg
Lenschow, D. J., Zeng, Y., Thistlethwaite, J. R., MONTAG, A. G., Brady, W., Gibson, M. G., Linsley, P. S., & Bluestone, J. A. (1992) · Science · doi:10.1126/science.1323143 · Cited by 1,121
Self-citation
THE NOD MOUSE: A Model of Immune Dysregulation
Anderson, M. S., & Bluestone, J. A. (2005) · Annual Review of Immunology · doi:10.1146/annurev.immunol.23.021704.115643 · Cited by 1,113
Self-citation
Control of peripheral T‐cell tolerance and autoimmunity via the CTLA‐4 and PD‐1 pathways
Fife, B. T., & Bluestone, J. A. (2008) · Immunological Reviews · doi:10.1111/j.1600-065x.2008.00662.x · Cited by 1,081
Self-citation
Interleukin-2 receptor α chain regulates the size and content of the peripheral lymphoid compartment
Willerford, D. M., Chen, J., Ferry, J. A., Davidson, L., Ma, A. I., & Alt, F. W. (1995) · Immunity · doi:10.1016/1074-7613(95)90180-9 · Cited by 1,079
Autoimmune T cell responses in the central nervous system
Goverman, J. M. (2009) · Nature reviews. Immunology · doi:10.1038/nri2550 · Cited by 1,055
The Foxp3+ regulatory T cell: a jack of all trades, master of regulation
Tang, Q., & Bluestone, J. A. (2008) · Nature Immunology · doi:10.1038/ni1572 · Cited by 1,045
Self-citation
T Cell Activation Determined by T Cell Receptor Number and Tunable Thresholds
Viola, A., & Lanzavecchia, A. (1996) · Science · doi:10.1126/science.273.5271.104 · Cited by 1,031
Function of PI3Kγ in Thymocyte Development, T Cell Activation, and Neutrophil Migration
Sasaki, T., Irie-Sasaki, J., Jones, R. G., Oliveira-dos-Santos, A., Stanford, W. L., Bolon, B. N., Wakeham, A. C., Itié, A., Bouchard, D., Kozieradzki, I., et al. (2000) · Science · doi:10.1126/science.287.5455.1040 · Cited by 1,027
Complexities of CD28/B7: CTLA-4 Costimulatory Pathways in Autoimmunity and Transplantation
Salomon, B. L., & Bluestone, J. A. (2001) · Annual Review of Immunology · doi:10.1146/annurev.immunol.19.1.225 · Cited by 1,001
Self-citation
Blockade of CTLA-4 on both effector and regulatory T cell compartments contributes to the antitumor activity of anti-CTLA-4 antibodies
Peggs, K. S., Quezada, S. A., Chambers, C. A., Korman, A. J., & Allison, J. P. (2009) · Journal of Experimental Medicine · doi:10.1084/jem.20082492 · Cited by 967
Selective Stimulation of T Cell Subsets with Antibody-Cytokine Immune Complexes
Boyman, O., Kovář, M., Rubinstein, M., Surh, C., & Sprent, J. (2006) · Science · doi:10.1126/science.1122927 · Cited by 940
T Lymphocyte Costimulation Mediated by Reorganization of Membrane Microdomains
Viola, A., Schroeder, S., Sakakibara, Y., & Lanzavecchia, A. (1999) · Science · doi:10.1126/science.283.5402.680 · Cited by 938
JNK is involved in signal integration during costimulation of T lymphocytes
Su, B., Jacinto, E., Hibi, M., Kallunki, T., Karin, M., & Ben‐Neriah, Y. (1994) · Cell · doi:10.1016/0092-8674(94)90056-6 · Cited by 907
CD28 and CTLA-4 coreceptor expression and signal transduction
Rudd, C. E., Taylor, A., & Schneider, H. (2009) · Immunological Reviews · doi:10.1111/j.1600-065x.2009.00770.x · Cited by 898
Deregulated T Cell Activation and Autoimmunity in Mice Lacking Interleukin-2 Receptor β
Suzuki, H., Kündig, T. M., Furlonger, C. L., Wakeham, A. C., Timms, E. M., Matsuyama, T., Schmits, R., Simard, J. J. L., Ohashi, P. S., Griesser, H., et al. (1995) · Science · doi:10.1126/science.7770771 · Cited by 870
Costimulation Blockade with Belatacept in Renal Transplantation
Vincenti, F. G., Larsen, C. P., Dürrbach, A., Wekerle, T., Nashan, B., Blancho, G., Lang, P., Grinyo, J. M., Halloran, P. F., Solez, K., et al. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa050085 · Cited by 857
CTLA-4 ligation blocks CD28-dependent T cell activation.
Walunas, T. L., Bakker, C. Y., & Bluestone, J. A. (1996) · The Journal of Experimental Medicine · doi:10.1084/jem.183.6.2541 · Cited by 801
Self-citation
Visualizing regulatory T cell control of autoimmune responses in nonobese diabetic mice
Tang, Q., Adams, J. Y., Tooley, A. J., Bi, M., Fife, B. T., Serra, P., Santamaría, P., Locksley, R. M., Krummel, M. F., & Bluestone, J. A. (2005) · Nature Immunology · doi:10.1038/ni1289 · Cited by 785
Self-citation
CD4 Regulatory T Cells Prevent Lethal Autoimmunity in IL-2Rβ-Deficient Mice
Malek, T. R., Yu, A., Vincek, V., Scibelli, P., & Kong, L. (2002) · Immunity · doi:10.1016/s1074-7613(02)00367-9 · Cited by 781
A regulatory polymorphism in PDCD1 is associated with susceptibility to systemic lupus erythematosus in humans
Prokunina‐Olsson, L., Castillejo-López, C., Oberg, F. G., Gunnarsson, I., Berg, L., Magnusson, V., Brookes, A. J., Tentler, D., Kristjansdóttir, H., Gröndal, G., et al. (2002) · Nature Genetics · doi:10.1038/ng1020 · Cited by 770
Interactions between PD-1 and PD-L1 promote tolerance by blocking the TCR–induced stop signal
Fife, B. T., Pauken, K. E., Eagar, T. N., Kangas, T. O., Wu, J. Q., Tang, Q., Azuma, M., Krummel, M. F., & Bluestone, J. A. (2009) · Nature Immunology · doi:10.1038/ni.1790 · Cited by 759
Self-citation
Foxp3 + natural regulatory T cells preferentially form aggregates on dendritic cells in vitro and actively inhibit their maturation
Onishi, Y., Fehervari, Z. T., Yamaguchi, T., & Sakaguchi, S. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0711106105 · Cited by 754
Randomised trial of basiliximab versus placebo for control of acute cellular rejection in renal allograft recipients
Nashan, B., Moore, R. H., Amlot, P. L., Schmidt, A.-G., Abeywickrama, K. H., & Soulillou, J. (1997) · The Lancet · doi:10.1016/s0140-6736(97)09278-7 · Cited by 746
Central Role of Defective Interleukin-2 Production in the Triggering of Islet Autoimmune Destruction
Tang, Q., Adams, J. Y., Penaranda, C., Melli, K., Piaggio, E., Sgouroudis, E., Piccirillo, C. A., Salomon, B. L., & Bluestone, J. A. (2008) · Immunity · doi:10.1016/j.immuni.2008.03.016 · Cited by 729
Self-citation
Rational Development of LEA29Y (belatacept), a High-Affinity Variant of CTLA4-Ig with Potent Immunosuppressive Properties
Larsen, C. P., Pearson, T. C., Adams, A. B., Tso, P. L., Shirasugi, N., Strobertb, E., Anderson, D., Cowan, S. R., Price, K., Naemura, J. R., et al. (2005) · American Journal of Transplantation · doi:10.1111/j.1600-6143.2005.00749.x · Cited by 721
Induction of Peripheral T Cell Tolerance In Vivo Requires CTLA-4 Engagement
Perez, V. L., Parijs, L. V., Biuckians, A., Zheng, X. X., Strom, T. B., & Abbas, A. K. (1997) · Immunity · doi:10.1016/s1074-7613(00)80284-8 · Cited by 715
Molecular Basis of T Cell Inactivation by CTLA-4
Lee, K.-M., Chuang, E., Griffin, M., Khattri, R., Hong, D. K., Zhang, W., Straus, D., Samelson, L. E., Thompson, C. B., & Bluestone, J. A. (1998) · Science · doi:10.1126/science.282.5397.2263 · Cited by 684
Self-citation
Foxp3 controls regulatory T-cell function by interacting with AML1/Runx1
Ono, M., Yaguchi, H., Ohkura, N., Kitabayashi, I., Nagamura, Y., Nomura, T., Miyachi, Y., Tsukada, T., & Sakaguchi, S. (2007) · Nature · doi:10.1038/nature05673 · Cited by 683
The Interaction Properties of Costimulatory Molecules Revisited
Collins, A. V., Brodie, D. W., Gilbert, R. J. C., Iaboni, A., Manso-Sancho, R., Walse, B., Stuart, D. I., van der Merwe, P. A., & Davis, S. J. (2002) · Immunity · doi:10.1016/s1074-7613(02)00362-x · Cited by 675
Cutting Edge: CD28 Controls Peripheral Homeostasis of CD4+CD25+ Regulatory T Cells
Tang, Q., Henriksen, K., Boden, E. K., Tooley, A. J., Ye, J., Subudhi, S. K., Zheng, X. X., Strom, T. B., & Bluestone, J. A. (2003) · The Journal of Immunology · doi:10.4049/jimmunol.171.7.3348 · Cited by 669
Self-citation
Treatment of Murine Lupus with CTLA4Ig
Finck, B. K., Linsley, P. S., & Wofsy, D. (1994) · Science · doi:10.1126/science.7520604 · Cited by 667
Immunologic and clinical effects of antibody blockade of cytotoxic T lymphocyte-associated antigen 4 in previously vaccinated cancer patients
Hodi, F. S., Butler, M., Oble, D. A., Seiden, M. V., Haluska, F. G., Kruse, A., MacRae, S., Nelson, M., Canning, C., Lowy, I., et al. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0712237105 · Cited by 650
Regulation of PD‐1, PD‐L1, and PD‐L2 expression during normal and autoimmune responses
Liang, S. C., Latchman, Y. E., Buhlmann, J. E., Tomczak, M. F., Horwitz, B. H., Freeman, G. J., & Sharpe, A. H. (2003) · European Journal of Immunology · doi:10.1002/eji.200324228 · Cited by 649
Biochemical Mechanisms of IL-2–Regulated Fas-Mediated T Cell Apoptosis
Refaeli, Y., Parijs, L. V., London, C. A., Tschopp, J., & Abbas, A. K. (1998) · Immunity · doi:10.1016/s1074-7613(00)80566-x · Cited by 639
IL-2 Is Essential for TGF-β to Convert Naive CD4+CD25− Cells to CD25+Foxp3+ Regulatory T Cells and for Expansion of These Cells
Zheng, S. G., Wang, J., Wang, P., Gray, J. D., & Horwitz, D. A. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.178.4.2018 · Cited by 613
CD28 costimulation of developing thymocytes induces Foxp3 expression and regulatory T cell differentiation independently of interleukin 2
Tai, X., Cowan, M. L., Feigenbaum, L., & Singer, A. (2005) · Nature Immunology · doi:10.1038/ni1160 · Cited by 613
Intracellular Trafficking of CTLA-4 and Focal Localization Towards Sites of TCR Engagement
Linsley, P. S., Bradshaw, J., Greene, J. L., Peach, R., Bennett, K. L., & Mittler, R. S. (1996) · Immunity · doi:10.1016/s1074-7613(00)80480-x · Cited by 608
CTLA4Ig-mediated blockade of T-cell costimulation in patients with psoriasis vulgaris
Abrams, J. R., Lebwohl, M., Guzzo, C. A., Jegasothy, B. V., Goldfarb, M. T., Goffe, B. S., Menter, A., Lowe, N. J., Krueger, G. G., Brown, M. J. C., et al. (1999) · Journal of Clinical Investigation · doi:10.1172/jci5857 · Cited by 597
Requirement for T-cell apoptosis in the induction of peripheral transplantation tolerance
Wells, A. D., Li, X. C., Li, Y., Walsh, M. C., Zheng, X. X., Wu, Z., Núñez, G., Tang, A., Sayegh, M. H., Hancock, W. W., et al. (1999) · Nature Medicine · doi:10.1038/15260 · Cited by 595
Antigen-dependent Proliferation of CD4+ CD25+ Regulatory T Cells In Vivo
Walker, L. S. K., Chodos, A. H., Eggena, M., Dooms, H., & Abbas, A. K. (2003) · The Journal of Experimental Medicine · doi:10.1084/jem.20030315 · Cited by 588
CD28 delivers a costimulatory signal involved in antigen-specific IL-2 production by human T cells
Jenkins, M. K., Taylor, P., Norton, S. D., & Urdahl, K. B. (1991) · The Journal of Immunology · doi:10.4049/jimmunol.147.8.2461 · Cited by 561
Abatacept in children with juvenile idiopathic arthritis: a randomised, double-blind, placebo-controlled withdrawal trial
Ruperto, N., Lovell, D. J., Quartier, P., Paz, E. G., Rubio‐Pérez, N., Silva, C. A., Abud‐Mendoza, C., Burgos‐Vargas, R., Gerloni, V., Melo‐Gomes, J. A., et al. (2008) · The Lancet · doi:10.1016/s0140-6736(08)60998-8 · Cited by 552
An intersection between the self-reactive regulatory and nonregulatory T cell receptor repertoires
Hsieh, C., Zheng, Y., Liang, Y., Fontenot, J. D., & Rudensky, A. Y. (2006) · Nature Immunology · doi:10.1038/ni1318 · Cited by 540
Cytotoxic T Lymphocyte Antigen-4 Accumulation in the Immunological Synapse Is Regulated by TCR Signal Strength
Egen, J. G., & Allison, J. P. (2002) · Immunity · doi:10.1016/s1074-7613(01)00259-x · Cited by 534
T-cell activation by the CD28 ligand B7 is required for cardiac allograft rejection in vivo.
Turka, L. A., Linsley, P. S., Lin, H., Brady, W., Leiden, J. M., Wei, R. Q., Gibson, M. L., Zheng, X. G., Myrdal, S. E., & Gordon, D. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.22.11102 · Cited by 533
A MOLECULAR PERSPECTIVE OF CTLA-4 FUNCTION
Teft, W. A., Kirchhof, M. G., & Madrenas, J. (2005) · Annual Review of Immunology · doi:10.1146/annurev.immunol.24.021605.090535 · Cited by 526
Cutting Edge: IL-2 Is Essential for TGF-β-Mediated Induction of Foxp3+ T Regulatory Cells
Davidson, T. S., DiPaolo, R. J., Andersson, J., & Shevach, E. M. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.178.7.4022 · Cited by 521
Continuous Activation of Autoreactive CD4+ CD25+ Regulatory T Cells in the Steady State
Fisson, S., Darrasse-Jèze, G., Litvinova, E., Septier, F., Klatzmann, D., Liblau, R., & Salomon, B. L. (2003) · The Journal of Experimental Medicine · doi:10.1084/jem.20030686 · Cited by 521
In vivo expansion of T reg cells with IL-2–mAb complexes: induction of resistance to EAE and long-term acceptance of islet allografts without immunosuppression
Webster, K. E., Walters, S. N., Kohler, R. E., Mrkvan, T., Boyman, O., Surh, C. D., Grey, S. T., & Sprent, J. (2009) · The Journal of Experimental Medicine · doi:10.1084/jem.20082824 · Cited by 513
Regulatory and Signaling Properties of the Vav Family
Bustelo, X. R. (2000) · Molecular and Cellular Biology · doi:10.1128/mcb.20.5.1461-1477.2000 · Cited by 507
Critical Role of the Programmed Death-1 (PD-1) Pathway in Regulation of Experimental Autoimmune Encephalomyelitis
Salama, A. D., Chitnis, T., Imitola, J., Ansari, M. J., Akiba, H., Tushima, F., Azuma, M., Yagita∥, H., Sayegh, M. H., & Khoury, S. J. (2003) · The Journal of Experimental Medicine · doi:10.1084/jem.20022119 · Cited by 506
Naive versus memory CD4 T cell response to antigen. Memory cells are less dependent on accessory cell costimulation and can respond to many antigen-presenting cell types including resting B cells.
Croft, M., Bradley, L. M., & Swain, S. L. (1994) · The Journal of Immunology · doi:10.4049/jimmunol.152.6.2675 · Cited by 500
Deletional Tolerance Mediated by Extrathymic Aire-Expressing Cells
Gardner, J. M., DeVoss, J., Friedman, R. S., Wong, D. J., Tan, Y. X., Zhou, X., Johannes, K., Su, M. A., Chang, H. Y., Krummel, M. F., et al. (2008) · Science · doi:10.1126/science.1159407 · Cited by 500
Crystal structure of the B7-1/CTLA-4 complex that inhibits human immune responses
Stamper, C. C., Zhang, Y., Tobin, J. F., Erbe, D. V., Ikemizu, S., Davis, S. J., Stahl, M., Seehra, J. S., Somers, W. S., & Mosyak, L. (2001) · Nature · doi:10.1038/35069118 · Cited by 487
Development and function of agonist-induced CD25+Foxp3+ regulatory T cells in the absence of interleukin 2 signaling
D’Cruz, L. M., & Klein, L. (2005) · Nature Immunology · doi:10.1038/ni1264 · Cited by 483
Mechanisms maintaining peripheral tolerance
Mueller, D. L. (2009) · Nature Immunology · doi:10.1038/ni.1817 · Cited by 481
Cutting Edge: Human CD4+CD25+ T Cells Restrain the Maturation and Antigen-Presenting Function of Dendritic Cells
Misra, N., Bayry, J., Lacroix‐Desmazes, S., Kazatchkine, M. D., & Kaveri, S. V. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.172.8.4676 · Cited by 477
IL-2 reverses established type 1 diabetes in NOD mice by a local effect on pancreatic regulatory T cells
Grinberg‐Bleyer, Y., Baeyens, A., You, S., Elhage, R., Fourcade, G., Grégoire, S., Cagnard, N., Carpentier, W., Tang, Q., Bluestone, J. A., et al. (2010) · The Journal of Experimental Medicine · doi:10.1084/jem.20100209 · Cited by 452
Self-citation
Establishment of NOD- Pdcd1 -/- mice as an efficient animal model of type I diabetes
Wang, J., Yoshida, T., Nakaki, F., Hiai, H., Okazaki, T., & Honjo, T. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0505497102 · Cited by 450
B7-1 and B7-2 Selectively Recruit CTLA-4 and CD28 to the Immunological Synapse
Pentcheva‐Hoang, T., Egen, J. G., Wojnoonski, K., & Allison, J. P. (2004) · Immunity · doi:10.1016/j.immuni.2004.06.017 · Cited by 446
Blockade of CTLA-4 on CD4+CD25+ regulatory T cells abrogates their function in vivo
Read, S., Greenwald, R., Izcue, A., Robinson, N., Mandelbrot, D., Francisco, L., Sharpe, A. H., & Powrie, F. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.177.7.4376 · Cited by 434
CTLA-4 and CD28 activated lymphocyte molecules are closely related in both mouse and human as to sequence, message expression, gene structure, and chromosomal location
Harper, K., Balzano, C., Rouvier, É., Mattéi, M., Luciani, M., & Golstein, P. (1991) · The Journal of Immunology · doi:10.4049/jimmunol.147.3.1037 · Cited by 432
Human immune disorder arising from mutation of the α chain of the interleukin-2 receptor
Sharfe, N., Dadi, H., Shahar, M., & Roifman, C. M. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.7.3168 · Cited by 405
Binding of phosphatidyl-inositol-3-OH kinase to CD28 is required for T-cell signalling
Pagès, F., Ragueneau, M., Rottapel, R. K., Truneh, A., Nunès, J. A., Imbert, J., & Olive, D. (1994) · Nature · doi:10.1038/369327a0 · Cited by 399
Unifying concepts in CD28, ICOS and CTLA4 co-receptor signalling.
Rudd, C. E., & Schneider, H. (2003) · Nature Reviews Immunology · doi:10.1038/nri1131 · Cited by 392 · cited 1×
“On one hand, the binding of Vav with the SH2 leukocyte protein of 76 kDa (SLP-76) ⁄ linker for activated T cells (LAT) complex activates PLCc1 that increases intracellular Ca and triggers PKCh function via the Bcl10 (B-cell lymphoma 10) ⁄MALT1 (mucosal associated lymphoid tissue 1) ⁄CARMA-1 [caspaserecruitment domain…”
Background
Nucleolin and YB-1 are required for JNK-mediated interleukin-2 mRNA stabilization during T-cell activationPreprint
Chen, C., Gherzi, R., Andersen, J., Gaietta, G. M., Jürchott, K., Royer, H. D., Mann, M., & Karin, M. (2000) · Genes & Development · doi:10.1101/gad.14.10.1236 · Cited by 380
Human regulatory T cells: role in autoimmune disease and therapeutic opportunities
Brusko, T. M., Putnam, A. L., & Bluestone, J. A. (2008) · Immunological Reviews · doi:10.1111/j.1600-065x.2008.00637.x · Cited by 379
Self-citation
Distinct roles of CTLA‐4 and TGF‐β in CD4+CD25+ regulatory T cell function
Tang, Q., Boden, E. K., Henriksen, K., Bour‐Jordan, H., Bi, M., & Bluestone, J. A. (2004) · European Journal of Immunology · doi:10.1002/eji.200425143 · Cited by 377
Self-citation
The efficacy and safety of abatacept in patients with non–life‐threatening manifestations of systemic lupus erythematosus: Results of a twelve‐month, multicenter, exploratory, phase IIb, randomized, double‐blind, placebo‐controlled trial
Merrill, J. T., Burgos‐Vargas, R., Westhovens, R., Chalmers, A., D’Cruz, D. P., Wallace, D. J., Bae, S., Sigal, L. H., Becker, J., Kelly, S., et al. (2010) · Arthritis & Rheumatism · doi:10.1002/art.27601 · Cited by 376
CD28/B7 Regulation of Th1 and Th2 Subsets in the Development of Autoimmune Diabetes
Lenschow, D. J., Herold, K. C., Rhee, L., Patel, B., Koons, A., Qin, H.-Y., Fuchs, E. V., Singh, B., Thompson, C. B., & Bluestone, J. A. (1996) · Immunity · doi:10.1016/s1074-7613(00)80323-4 · Cited by 369
Self-citation
Interleukin-2 gene variation impairs regulatory T cell function and causes autoimmunity
Yamanouchi, J., Rainbow, D., Serra, P., Howlett, S., Hunter, K. M. D., Garner, V. E. S., González-Muñoz, A., Clark, J., Veijola, R., Cubbon, R. M., et al. (2007) · Nature Genetics · doi:10.1038/ng1958 · Cited by 367
Localization of a Type 1 Diabetes Locus in the IL2RA/CD25 Region by Use of Tag Single-Nucleotide Polymorphisms
Vella, A. V., Cooper, J. D., Lowe, C. E., Walker, N. M., Nutland, S. L., Widmer, B., Jones, R. W., Ring, S. M., McArdle, W. L., Pembrey, M. E., et al. (2005) · The American Journal of Human Genetics · doi:10.1086/429843 · Cited by 363
Duration of TCR Stimulation Determines Costimulatory Requirement of T Cells
Kündig, T. M., Shahinian, A., Kawai, K., Mittrücker, H., Sebzda, E., Bachmann, M. F., Mak, T. W., & Ohashi, P. S. (1996) · Immunity · doi:10.1016/s1074-7613(00)80308-8 · Cited by 355
Structural basis for co-stimulation by the human CTLA-4/B7-2 complex
Schwartz, J.-C. D., Zhang, X., Fedorov, A. A., Nathenson, S. G., & Almo, S. C. (2001) · Nature · doi:10.1038/35069112 · Cited by 350
Staging and resetting T cell activation in SMACs
Freiberg, B. A., Kupfer, H., Maslanik, W., Delli, J., Kappler, J. W., Zaller, D. M., & Kupfer, A. (2002) · Nature Immunology · doi:10.1038/ni836 · Cited by 350
P hosphoinositide 3-K inase : Diverse Roles in Immune Cell Activation
Deane, J. A., & Fruman, D. A. (2004) · Annual Review of Immunology · doi:10.1146/annurev.immunol.22.012703.104721 · Cited by 347
Tyrosine Phosphorylation Controls Internalization of CTLA-4 by Regulating Its Interaction with Clathrin-Associated Adaptor Complex AP-2
Shiratori, T., Miyatake, S., Ohno, H., Nakaseko, C., Isono, K., Bonifacino, J. S., & Saito, T. (1997) · Immunity · doi:10.1016/s1074-7613(00)80346-5 · Cited by 345
Cytotoxic T lymphocyte antigen‐4‐dependent down‐modulation of costimulatory molecules on dendritic cells in CD4 + CD25 + regulatory T‐cell‐mediated suppression
Oderup, C., Cederbom, L., Makowska, A. M., Cilio, C., & Ivars, F. (2006) · Immunology · doi:10.1111/j.1365-2567.2006.02362.x · Cited by 335
Genomic expression programs and the integration of the CD28 costimulatory signal in T cell activation
Diehn, M., Alizadeh, A. A., Rando, O. J., Liu, C. L., Stankunas, K., Botstein, D., Crabtree, G. R., & Brown, P. O. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.092284399 · Cited by 332
Insulin-induced remission in new-onset NOD mice is maintained by the PD-1–PD-L1 pathway
Fife, B. T., Guleria, I., Bupp, M. G., Eagar, T. N., Tang, Q., Bour-Jordan, H., Yagita∥, H., Azuma, M., Sayegh, M. H., & Bluestone, J. A. (2006) · The Journal of Experimental Medicine · doi:10.1084/jem.20061577 · Cited by 331
Self-citation
Spatiotemporal Regulation of T Cell Costimulation by TCR-CD28 Microclusters and Protein Kinase C θ Translocation
Yokosuka, T., Kobayashi, W., Sakata-Sogawa, K., Takamatsu, M., Hashimoto, A. S., Dustin, M. L., Tokunaga, M., & Saito, T. (2008) · Immunity · doi:10.1016/j.immuni.2008.08.011 · Cited by 320
Akt provides the CD28 costimulatory signal for up-regulation of IL-2 and IFN-γ but not TH2 cytokines
Kane, L. P., Andres, P. G., Howland, K. C., Abbas, A. K., & Weiss, A. (2001) · Nature Immunology · doi:10.1038/83144 · Cited by 316
PD-L1 negatively regulates CD4+CD25+Foxp3+ Tregs by limiting STAT-5 phosphorylation in patients chronically infected with HCV
Franceschini, D., Paroli, M., Francavilla, V., Videtta, M., Morrone, S., Labbadia, G., Cerino, A., Mondelli, M. U., & Barnaba, V. (2009) · Journal of Clinical Investigation · doi:10.1172/jci36604 · Cited by 316
Characterization of CTLA-4 structure and expression on human T cells.
Lindsten, T., Lee, K. P., Harris, E. S., Petryniak, B., Craighead, N., Reynolds, P. J., Lombard, D. B., Freeman, G. J., Nadler, L. M., Gray, G. S., et al. (1993) · The Journal of Immunology · doi:10.4049/jimmunol.151.7.3489 · Cited by 316
Functional Responses and Costimulator Dependence of Memory CD4+ T Cells
London, C. A., Lodge, M. P., & Abbas, A. K. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.164.1.265 · Cited by 314
The immunological synapse and CD28-CD80 interactions
Bromley, S. K., Iaboni, A., Davis, S. J., Whitty, A., Green, J. M., Shaw, A. S., Weiss, A., & Dustin, M. L. (2001) · Nature Immunology · doi:10.1038/ni737 · Cited by 311
Modulation of TCR-induced transcriptional profiles by ligation of CD28, ICOS, and CTLA-4 receptors
Riley, J. L., Mao, M., Kobayashi, S., Biery, M. C., Burchard, J., Cavet, G., Gregson, B. P., June, C. H., & Linsley, P. S. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.162359999 · Cited by 307
The CD28 and CTLA-4 Receptors Associate with the Serine/Threonine Phosphatase PP2A
Chuang, E., Fisher, T. S., Morgan, R. W., Robbins, M. D., Duerr, J. M., Vander Heiden, M. G., Gardner, J. P., Hambor, J. E., Neveu, M. J., & Thompson, C. B. (2000) · Immunity · doi:10.1016/s1074-7613(00)00031-5 · Cited by 303 · cited 5×
“Guntermann C, Alexander DR. CTLA-4 suppresses proximal TCR signaling in resting human CD4(+) T cells by inhibiting ZAP- 70 Tyr(319) phosphorylation: a potential role for tyrosine phosphatases.”
BackgroundInfluential
The role of CD28 and cytotoxic T‐lymphocyte antigen‐4 (CTLA‐4) in regulatory T‐cell biology
Sansom, D. M., & Walker, L. S. K. (2006) · Immunological Reviews · doi:10.1111/j.0105-2896.2006.00419.x · Cited by 294
CD28 costimulation promotes the production of Th2 cytokines
Rulifson, I. C., Sperling, A. I., Fields, P. E., Fitch, F. W., & Bluestone, J. A. (1997) · The Journal of Immunology · doi:10.4049/jimmunol.158.2.658 · Cited by 291
Self-citation
CTLA4 gene polymorphism and autoimmunity
Gough, S. C. L., Walker, L. S. K., & Sansom, D. M. (2005) · Immunological Reviews · doi:10.1111/j.0105-2896.2005.00249.x · Cited by 291
Differential expression of PD-L1 and PD-L2, ligands for an inhibitory receptor PD-1, in the cells of lymphohematopoietic tissues
Ishida, M., Iwai, Y., Tanaka, Y., Okazaki, T., Freeman, G. J., Minato, N., & Honjo, T. (2002) · Immunology Letters · doi:10.1016/s0165-2478(02)00142-6 · Cited by 284
CTLA4Ig: Bridging the Basic Immunology with Clinical Application
Bluestone, J. A., Clair, E. W. S., & Turka, L. A. (2006) · Immunity · doi:10.1016/j.immuni.2006.03.001 · Cited by 279
Self-citation
CD86 and CD80 Differentially Modulate the Suppressive Function of Human Regulatory T Cells
Zheng, Y., Manzotti, C. N., Liu, M., Burke, F., Mead, K. I., & Sansom, D. M. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.172.5.2778 · Cited by 277
Apoptosis Regulators Fas and Bim Cooperate in Shutdown of Chronic Immune Responses and Prevention of Autoimmunity
Hughes, P., Belz, G. T., Fortner, K. A., Budd, R. C., Strasser, A., & Bouillet, P. (2008) · Immunity · doi:10.1016/j.immuni.2007.12.017 · Cited by 271
CD4+ regulatory T cells require CTLA-4 for the maintenance of systemic tolerance
Friedline, R. H., Brown, D. S., Nguyen, H., Kornfeld, H., Lee, J., Zhang, Y., Appleby, M. W., Der, S. D., Kang, J., & Chambers, C. A. (2009) · The Journal of Experimental Medicine · doi:10.1084/jem.20081811 · Cited by 266
Developmentally regulated expression of the PD-1 protein on the surface of double-negative(CD4–CD8–) thymocytes
Nishimura, H., Agata, Y., Kawasaki, A., Sato, M., Imamura, S., Minato, N., Yagita∥, H., Nakano, T., & Honjo, T. (1996) · International Immunology · doi:10.1093/intimm/8.5.773 · Cited by 261
Interleukin‐2 in the development and control of inflammatory disease
Hoyer, K. K., Dooms, H., Barron, L., & Abbas, A. K. (2008) · Immunological Reviews · doi:10.1111/j.1600-065x.2008.00697.x · Cited by 259
A PD‐1 polymorphism is associated with disease progression in multiple sclerosis
Kroner, A., Mehling, M., Hemmer, B., Rieckmann, P., Toyka, K. V., Mäurer, M., & Wiendl, H. (2005) · Annals of Neurology · doi:10.1002/ana.20514 · Cited by 258
Dual function of CTLA-4 in regulatory T cells and conventional T cells to prevent multiorgan autoimmunity
Jain, N., Nguyen, H., Chambers, C. A., & Kang, J. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0910341107 · Cited by 253
Structural Analysis of CTLA-4 Function In Vivo
Masteller, E. L., Chuang, E., Mullen, A. C., Reiner, S. L., & Thompson, C. B. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.164.10.5319 · Cited by 252 · cited 1×
“The overall importance of the cytoplasmic tail and the Y201VKM sequence is most evident in CTLA-4 mutant mice that either lack the entire intracellular domain or carry a point mutation within the Y201VKM motif (139, 140).”
Background
Complementarity determining region 1 (CDR1)- and CDR3-analogous regions in CTLA-4 and CD28 determine the binding to B7-1.
Peach, R., Bajorath, J., Brady, W., Leytze, G., Greene, J. L., Naemura, J. R., & Linsley, P. S. (1994) · The Journal of Experimental Medicine · doi:10.1084/jem.180.6.2049 · Cited by 248
Regulation of CTLA-4 expression during T cell activation
Perkins, D. L., Wang, Z., Donovan, C., He, H., Mark, D. A., Guan, G., Wang, Y., Walunas, T. L., Bluestone, J. A., Listman, J. A., et al. (1996) · The Journal of Immunology · doi:10.4049/jimmunol.156.11.4154 · Cited by 244
Self-citation
Cutting Edge: A Soluble Form of CTLA-4 in Patients with Autoimmune Thyroid Disease
Oaks, M. K., & Hallett, K. M. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.164.10.5015 · Cited by 239
Transcription factor Foxo3 controls the magnitude of T cell immune responses by modulating the function of dendritic cells
Dejean, A. S., Beisner, D. R., Ch’en, I. L., Kerdiles, Y. M., Babour, A., Arden, K. C., Castrillón, D. H., DePinho, R. A., & Hedrick, S. Μ. (2009) · Nature Immunology · doi:10.1038/ni.1729 · Cited by 238
Altered activation of AKT is required for the suppressive function of human CD4+CD25+ T regulatory cells
Crellin, N. K., García, R., & Levings, M. K. (2006) · Blood · doi:10.1182/blood-2006-07-035279 · Cited by 235
Development of Spontaneous Autoimmune Peripheral Polyneuropathy in B7-2–Deficient Nod Mice
Salomon, B. L., Rhee, L., Bour-Jordan, H., Hsin, H., MONTAG, A. G., Soliven, B. C., Arcella, J., Girvin, A. M., Miller, S. D., & Bluestone, J. A. (2001) · The Journal of Experimental Medicine · doi:10.1084/jem.194.5.677 · Cited by 235
Self-citation
The Effect of Costimulatory and Interleukin 2 Receptor Blockade on Regulatory T Cells in Renal Transplantation
Bluestone, J. A., Liu, W., Yabu, J. M., Laszik, Z. G., Putnam, A. L., Belingheri, M., Gross, D. M., Townsend, R. M., & Vincenti, F. G. (2008) · American Journal of Transplantation · doi:10.1111/j.1600-6143.2008.02377.x · Cited by 233
Self-citation
Cutting Edge: Lymphoproliferative Disease in the Absence of CTLA-4 Is Not T Cell Autonomous
Bachmann, M. F., Köhler, G., Ecabert, B., Mak, T. W., & Köpf, M. (1999) · The Journal of Immunology · doi:10.4049/jimmunol.163.3.1128 · Cited by 232
Association of a putative regulatory polymorphism in the PD‐1 gene with susceptibility to type 1 diabetes
Nielsen, C., Hansen, D., Husby, S., Jacobsen, B. B., & Lillevang, S. T. (2003) · Tissue Antigens · doi:10.1046/j.1399-0039.2003.00136.x · Cited by 232
Cell intrinsic mechanisms of T‐cell inhibition and application to cancer therapy
Peggs, K. S., Quezada, S. A., & Allison, J. P. (2008) · Immunological Reviews · doi:10.1111/j.1600-065x.2008.00649.x · Cited by 232
Regulating the regulators: costimulatory signals control the homeostasis and function of regulatory T cells
Bour‐Jordan, H., & Bluestone, J. A. (2009) · Immunological Reviews · doi:10.1111/j.1600-065x.2009.00775.x · Cited by 229
Self-citation
Interaction of CTLA-4 with the clathrin-associated protein AP50 results in ligand-independent endocytosis that limits cell surface expression
Chuang, E., Alegre, M., Duckett, C. S., Noel, P. J., Heiden, M. G. V., & Thompson, C. B. (1997) · The Journal of Immunology · doi:10.4049/jimmunol.159.1.144 · Cited by 225
Spatiotemporal Basis of CTLA-4 Costimulatory Molecule-Mediated Negative Regulation of T Cell Activation
Yokosuka, T., Kobayashi, W., Takamatsu, M., Sakata-Sogawa, K., Zeng, H., Hashimoto, A. S., Yagita∥, H., Tokunaga, M., & Saito, T. (2010) · Immunity · doi:10.1016/j.immuni.2010.09.006 · Cited by 224
Cutting Edge: Mechanisms of IL-2–Dependent Maintenance of Functional Regulatory T Cells
Barron, L., Dooms, H., Hoyer, K. K., Kuswanto, W. F., Hofmann, J., O’Gorman, W. E., & Abbas, A. K. (2010) · The Journal of Immunology · doi:10.4049/jimmunol.0903940 · Cited by 224
An Autoimmune Disease-Associated CTLA-4 Splice Variant Lacking the B7 Binding Domain Signals Negatively in T Cells
Vijayakrishnan, L., Slavik, J. M., Illés, Z., Greenwald, R. J., Rainbow, D., Greve, B., Peterson, L. B., Hafler, D. A., Freeman, G. J., Sharpe, A. H., et al. (2004) · Immunity · doi:10.1016/s1074-7613(04)00110-4 · Cited by 221
Control of Foxp3+ CD25+CD4+ regulatory cell activation and function by dendritic cells
Fehervari, Z. T. (2004) · International Immunology · doi:10.1093/intimm/dxh178 · Cited by 221
CD28 Mediates Transcriptional Upregulation of the Interleukin-2 (IL-2) Promoter through a Composite Element Containing the CD28RE and NF-IL-2B AP-1 Sites
Shapiro, V. S., Truitt, K. E., Imboden, J. B., & Weiss, A. (1997) · Molecular and Cellular Biology · doi:10.1128/mcb.17.7.4051 · Cited by 213
A point mutation in CD28 distinguishes proliferative signals from survival signals.
Okkenhaug, K., Wu, L., Garza, K. M., La Rose, J., Khoo, W., Odermatt, B., Mak, T. W., Ohashi, P. S., & Rottapel, R. (2001) · Nature Immunology · doi:10.1038/86327 · Cited by 210
CD28/B7 interactions deliver a unique signal to naive T cells that regulates cell survival but not early proliferation
Sperling, A. I., Auger, J., Ehst, B. D., Rulifson, I. C., Thompson, C. B., & Bluestone, J. A. (1996) · The Journal of Immunology · doi:10.4049/jimmunol.157.9.3909 · Cited by 210
Self-citation
CD28 Costimulation Mediates T Cell Expansion Via IL-2-Independent and IL-2-Dependent Regulation of Cell Cycle Progression
Appleman, L. J., Berezovskaya, A., Grass, I., & Boussiotis, V. A. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.164.1.144 · Cited by 210
Autoantigen-Specific TGFβ-Induced Foxp3+ Regulatory T Cells Prevent Autoimmunity by Inhibiting Dendritic Cells from Activating Autoreactive T Cells
DiPaolo, R. J., Brinster, C., Davidson, T. S., Andersson, J., Glass, D. D., & Shevach, E. M. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.179.7.4685 · Cited by 209
Selective targeting of regulatory T cells with CD28 superagonists allows effective therapy of experimental autoimmune encephalomyelitis
Beyersdorf, N., Gaupp, S., Balbach, K., Schmidt, J., Toyka, K. V., Lin, C.-H., Hanke, T., Hünig, T., Kerkau, T., & Gold, R. (2005) · The Journal of Experimental Medicine · doi:10.1084/jem.20051060 · Cited by 203
Topological requirements and signaling properties of T cell-activating, anti-CD28 antibody superagonists.
Lühder, F., Huang, Y., Dennehy, K. M., Guntermann, C., Müller, I., Winkler, E., Kerkau, T., Ikemizu, S., Davis, S. J., Hanke, T., et al. (2003) · The Journal of Experimental Medicine · doi:10.1084/jem.20021024 · Cited by 193
Continuous control of autoimmune disease by antigen-dependent polyclonal CD4+CD25+ regulatory T cells in the regional lymph node
Samy, E. T., Parker, L. A., Sharp, C., & Tung, K. S. K. (2005) · The Journal of Experimental Medicine · doi:10.1084/jem.20041033 · Cited by 188
CTLA4Ig prevents lymphoproliferation and fatal multiorgan tissue destruction in CTLA-4-deficient mice
Tivol, E. A., Boyd, S. D., Mckeon, S., Borriello, F., Nickerson, P. W., Strom, T. B., & Sharpe, A. H. (1997) · The Journal of Immunology · doi:10.4049/jimmunol.158.11.5091 · Cited by 185
Proline Residues in Cd28 and the Src Homology (Sh)3 Domain of Lck Are Required for T Cell Costimulation
Holdorf, A. D., Green, J. M., Levin, S. D., Denny, M. F., Straus, D. B., Link, V., Changelian, P. S., Allen, P. M., & Shaw, A. S. (1999) · The Journal of Experimental Medicine · doi:10.1084/jem.190.3.375 · Cited by 185
Lymphoproliferative Disorder in CTLA-4 Knockout Mice Is Characterized by CD28-Regulated Activation of Th2 Responses
Khattri, R., Auger, J., Griffin, M. D., Sharpe, A. H., & Bluestone, J. A. (1999) · The Journal of Immunology · doi:10.4049/jimmunol.162.10.5784 · Cited by 181
Self-citation
Interaction of CTLA-4 with AP50, a clathrin-coated pit adaptor protein
Zhang, Y., & Allison, J. P. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.17.9273 · Cited by 181
CTLA‐4: a key regulatory point in the control of autoimmune disease
Scalapino, K. J., & Daikh, D. (2008) · Immunological Reviews · doi:10.1111/j.1600-065x.2008.00639.x · Cited by 177
CTLA-4 trafficking and surface expression
Valk, E., Rudd, C. E., & Schneider, H. (2008) · Trends in Immunology · doi:10.1016/j.it.2008.02.011 · Cited by 177
CTLA-4 suppresses the pathogenicity of self antigen–specific T cells by cell-intrinsic and cell-extrinsic mechanisms
Ise, W., Kohyama, M., Nutsch, K., Lee, H. M., Suri, A., Unanue, E. R., Murphy, T. L., & MURPHY, K. M. M. (2009) · Nature Immunology · doi:10.1038/ni.1835 · Cited by 177
The Roles of CD28 and CD40 Ligand in T Cell Activation and Tolerance
Howland, K. C., Ausubel, L. J., London, C. A., & Abbas, A. K. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.164.9.4465 · Cited by 173
Suppression of apoptosis in a cytotoxic T-cell line by interleukin 2-mediated gene transcription and deregulated expression of the protooncogene bcl-2.
Deng, G., & Podack, E. R. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.6.2189 · Cited by 173
Signaling through CD28 and CTLA-4 controls two distinct forms of T cell anergy
Wells, A. D., Walsh, M. C., Bluestone, J. A., & Turka, L. A. (2001) · Journal of Clinical Investigation · doi:10.1172/jci13220 · Cited by 172
Self-citation
Impaired Alloantigen-Mediated T Cell Apoptosis and Failure To Induce Long-Term Allograft Survival in IL-2-Deficient Mice
Dai, Z., Konieczny, B. T., Baddoura, F. K., & Lakkis, F. G. (1998) · The Journal of Immunology · doi:10.4049/jimmunol.161.4.1659 · Cited by 171
The inhibitory function of B7 costimulators in T cell responses to foreign and self-antigens
Lohr, J. G., Knoechel, B., Jiang, S., Sharpe, A. H., & Abbas, A. K. (2003) · Nature Immunology · doi:10.1038/ni939 · Cited by 170
CTLA-4 binding to the lipid kinase phosphatidylinositol 3-kinase in T cells.
Schneider, H. E., Prasad, K. V., Shoelson, S. E., & Rudd, C. E. (1995) · The Journal of Experimental Medicine · doi:10.1084/jem.181.1.351 · Cited by 164
CD28 interaction with filamin-A controls lipid raft accumulation at the T-cell immunological synapse
Tavano, R., Contento, R. L., Baranda, S. J., Soligo, M., Tuosto, L., Mañes, S., & Viola, A. (2006) · Nature Cell Biology · doi:10.1038/ncb1492 · Cited by 161
The clinical utility of inhibiting CD28‐mediated costimulation
Linsley, P. S., & Nadler, S. G. (2009) · Immunological Reviews · doi:10.1111/j.1600-065x.2009.00780.x · Cited by 160
The Basis for IL-2-Induced IL-2 Receptor α Chain Gene Regulation
Kim, H., Kelly, J., & Leonard, W. J. (2001) · Immunity · doi:10.1016/s1074-7613(01)00167-4 · Cited by 157
Costimulation controls diabetes by altering the balance of pathogenic and regulatory T cells
Bour-Jordan, H., Salomon, B. L., Thompson, H. L., Szot, G. L., Bernhard, M. R., & Bluestone, J. A. (2004) · Journal of Clinical Investigation · doi:10.1172/jci20483 · Cited by 157
Self-citation
CTLA-4 Controls Regulatory T Cell Peripheral Homeostasis and Is Required for Suppression of Pancreatic Islet Autoimmunity
Schmidt, E. M., Wang, C. J., Ryan, G. A., Clough, L. E., Qureshi, O., Goodall, M. D., Abbas, A. K., Sharpe, A. H., Sansom, D. M., & Walker, L. S. K. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.182.1.274 · Cited by 155
The Initial Phase of an Immune Response Functions to Activate Regulatory T Cells
O’Gorman, W. E., Dooms, H., Thorne, S. H., Kuswanto, W. F., Simonds, E. F., Krutzik, P. O., Nolan, G. P., & Abbas, A. K. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0900691 · Cited by 152
Cytotoxic T Lymphocyte Antigen 4 (CTLA-4) Interferes with Extracellular Signal-regulated Kinase (ERK) and Jun NH2-terminal Kinase (JNK) Activation, but Does Not Affect Phosphorylation of T Cell Receptor ζ and ZAP70
Revilla, C., Amsen, D., & Kruisbeek, A. M. (1997) · The Journal of Experimental Medicine · doi:10.1084/jem.186.10.1645 · Cited by 151
Cutting Edge: Distinct Motifs Within CD28 Regulate T Cell Proliferation and Induction of Bcl-XL
Burr, J. S., Savage, N. D. L., Messah, G. E., Kimzey, S. L., Shaw, A. S., Arch, R. H., & Green, J. M. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.166.9.5331 · Cited by 149
B7-1 or B7-2 Is Required to Produce the Lymphoproliferative Phenotype in Mice Lacking Cytotoxic T Lymphocyte–associated Antigen 4 (CTLA-4)
Mandelbrot, D. A., McAdam, A. J., & Sharpe, A. H. (1999) · The Journal of Experimental Medicine · doi:10.1084/jem.189.2.435 · Cited by 142
Immunopathology of interleukin (IL) 2-deficient mice: thymus dependence and suppression by thymus-dependent cells with an intact IL-2 gene.
Krämer, S., Schimpl, A., & Hünig, T. (1995) · The Journal of Experimental Medicine · doi:10.1084/jem.182.6.1769 · Cited by 142
Costimulation controls diabetes by altering the balance of pathogenic and regulatory T cells
Bour-Jordan, H., Salomon, B. L., Thompson, H. L., et al. (2004) · Journal of Clinical Investigation · doi:10.1172/jci200420483 · Cited by 142
Self-citation
T Cell–specific Ablation of Fas Leads to Fas Ligand–mediated Lymphocyte Depletion and Inflammatory Pulmonary Fibrosis
Hao, Z., Hampel, B., Yagita∥, H., & Rajewsky, K. (2004) · The Journal of Experimental Medicine · doi:10.1084/jem.20032196 · Cited by 139
Congenic Mapping of the Type 1 Diabetes Locus,Idd3, to a 780-kb Region of Mouse Chromosome 3: Identification of a Candidate Segment of Ancestral DNA by Haplotype MappingPreprint
Lyons, P., Armitage, N., Argentina, F., Denny, P., Hill, N. J., Lord, C. J., Wilusz, M. B., Peterson, L. B., Wicker, L. S., & Todd, J. A. (2000) · Genome Research · doi:10.1101/gr.10.4.446 · Cited by 139
Memory CD8+ T Cells Require CD28 Costimulation
Borowski, A. B., Boesteanu, A. C., Mueller, Y. M., Carafides, C., Topham, D. J., Altman, J. D., Jennings, S. R., & Katsikis, P. D. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.179.10.6494 · Cited by 137
Inhibition of T cell costimulation abrogates airway hyperresponsiveness in a murine model.
Krinzman, S. J., Sanctis, G. T. D., Cernadas, M., Mark, D. A., Wang, Y., Listman, J. A., Kobzik, L., Donovan, C., Nassr, K., Katona, I. M., et al. (1996) · Journal of Clinical Investigation · doi:10.1172/jci119093 · Cited by 136

Sorted by citations

CTLA-4: a moving target in immunotherapy
Rowshanravan, B., Halliday, N., & Sansom, D. M. (2018) · Blood · doi:10.1182/blood-2017-06-741033 · Cited by 1,233
CD28 Costimulation: From Mechanism to Therapy
Esensten, J. H., Helou, Y. A., Chopra, G., Weiss, A., & Bluestone, J. A. (2016) · Immunity · doi:10.1016/j.immuni.2016.04.020 · Cited by 937
Self-citation
Collateral damage: Insulin-dependent diabetes induced with checkpoint inhibitors
Stamatouli, A. M., Quandt, Z., Perdigoto, A. L., Clark, P. L., Kluger, H., Weiss, S. A., Gettinger, S., Sznol, M., Young, A., Rushakoff, R., et al. (2018) · Diabetes · doi:10.2337/dbi18-0002 · Cited by 590
Self-citation
The Evolving Role of CD8+CD28− Immunosenescent T Cells in Cancer Immunology
Huff, W. X., Kwon, J. H., Henriquez, M., Fetcko, K., & Dey, M. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20112810 · Cited by 217
p53 isoforms regulate aging- and tumor-associated replicative senescence in T lymphocytes
Mondal, A. M., Horikawa, I., Pine, S. R., Fujita, K., Morgan, K. M., Vera, E., Mazur, S. J., Appella, E., Vojtesek, B., Blasco, M. A., et al. (2013) · Journal of Clinical Investigation · doi:10.1172/jci70355 · Cited by 164

See all 391

Authors: Bour‐Jordan, H., Esensten, J. H., Martinez‐Llordella, M., Penaranda, C., Stumpf, M., & Bluestone, J. A.
Affiliations: University of California, San Francisco (US)
Corresponding author: Bluestone, Jeffrey A.
ORCID: Esensten, Jonathan H.
Bluestone, Jeffrey A.
Venue: Immunological Reviews
Publisher: Wiley
Published: 2011-04-13
Volume: 241
Issue: 1
Pages: 180-205
ISSN: 0105-2896 (ISSN-L)
1600-065X
DOI: 10.1111/j.1600-065x.2011.01011.x
PMC: PMC3077803
OpenAlex: W1907829837
Cited by: 391
References: 278
Citations by year: 2026: 6 · 2025: 13 · 2024: 15 · 2023: 12 · 2022: 13 · 2021: 26 · 2020: 17 · 2019: 23 · 2018: 20 · 2017: 26 · 2016: 34 · 2015: 47 · 2014: 36 · 2013: 49 · 2012: 40
FWCI: 4.00
Type: journal article
Language: en
Open access: green
www.ncbi.nlm.nih.gov
Licence: onlinelibrary.wiley.com/termsAndConditions#vor (vor)
Locations: Immunological Reviews (publishedVersion)
PubMed (publishedVersion)
Europe PMC (PubMed Central) (acceptedVersion)
PubMed Central (acceptedVersion)
Research Portal (King's College London) (submittedVersion)
Funders: National Institute of Allergy and Infectious Diseases (P01AI035294, R01AI050834, R37AI046643)
National Institute of Diabetes and Digestive and Kidney Diseases (P30DK063720)
Topics: Life Sciences › Immunology and Microbiology › Immunology › T-cell and B-cell Immunology
Life Sciences › Immunology and Microbiology › Immunology › Immunotherapy and Immune Responses
Health Sciences › Medicine › Oncology › Cancer Immunotherapy and Biomarkers
Keywords: peripheral T cell tolerance, CD28/B7 costimulation, CD28, CTLA-4, PD-1, interleukin-2, regulatory T cells, antigen-presenting cells, costimulatory pathways
MeSH terms: Animals, Antigen-Presenting Cells, Autoimmune Diseases, Graft Rejection, Humans, Immune Tolerance, Immunotherapy, Neoplasms, Antigens, CD, T-Lymphocyte Subsets, CD28 Antigens, B7-1 Antigen, Receptor Cross-Talk, T-Lymphocytes, Regulatory, Apoptosis Regulatory Proteins, CTLA-4 Antigen, Programmed Cell Death 1 Receptor

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Intrinsic and extrinsic control of peripheral T‐cell tolerance by costimulatory molecules of the CD28/ B7 family

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks